Arcadia Biosciences, Inc. Material Event - What Happened

This report explains the latest news from Arcadia Biosciences in plain English. If you follow the stock or are interested in the company, here is what you need to know.

---

1. What happened?

Arcadia Biosciences released its 2025 year-end financial results and a strategic update. Most importantly, Arcadia and Roosevelt Resources mutually ended their merger agreement. To boost its cash reserves after the deal collapsed, Arcadia raised about $2.1 million by selling new preferred stock and warrants to private investors.

2. When did it happen?

The company officially released this news in a filing on March 26, 2026.

3. Why does this matter?

These reports show the reality behind the company’s marketing. Here is the takeaway:

• The Good News: The Zola® coconut water brand is growing. Sales rose 17% over the last year to about $8.2 million. Management also cut operating expenses by 22%, which helped reduce the company’s loss and kept it running longer.
• The Reality Check: Despite these cuts, the company still lost about $4.8 million this year. Management admitted that current cash is not enough to fund operations for the next 12 months. They will likely need to raise more money soon, which will likely mean issuing more shares and reducing your ownership percentage.

4. Who is affected?

• Investors: The stock price may be volatile because the merger failed. Because the company relies on selling more shares to fund operations, your ownership percentage will likely decrease as new shares are issued.
• Employees: The company cut staff and overhead to save cash. This creates a high-pressure environment where the remaining team must focus entirely on selling Zola.
• Customers: You can expect more aggressive marketing and store expansion for Zola, as the company is putting all its resources into this one product.

5. What happens next?

Arcadia is currently in a "wait and see" phase. The board is looking for new options, such as finding a new merger partner, selling the Zola brand, or selling the entire company. The company didn't provide specific details on potential buyers or timelines, so watch future reports for updates on their ability to stay in business and how they plan to cover their funding gap.

6. What should investors know?

• The "Zola" Story: This is the company's main asset. Watch how fast Zola sells in stores and whether the company can keep growing sales without spending too much on marketing.
• Watch the Cash: The company’s cash level is the most important metric. With a $4.8 million annual loss and only $2.1 million raised, the company remains fragile.
• The Bottom Line: Arcadia is a small company in transition. While cost-cutting helped, the company is not yet profitable and needs outside cash to survive, making it a high-risk investment.

---

Disclaimer: I am an AI, not a financial advisor. This summary is for informational purposes only and does not constitute financial advice. Always do your own research before making investment decisions.